IRIS
DE FABRITIIS, PAOLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 34.498
AS - Asia 4.027
EU - Europa 2.946
SA - Sud America 772
AF - Africa 60
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 7
Totale 42.318
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 34.383
SG - Singapore 2.175
CN - Cina 660
BR - Brasile 640
DE - Germania 593
HK - Hong Kong 586
IT - Italia 516
UA - Ucraina 439
IE - Irlanda 379
RU - Federazione Russa 312
GB - Regno Unito 215
VN - Vietnam 206
FI - Finlandia 105
KR - Corea 95
SE - Svezia 92
FR - Francia 89
CA - Canada 54
IN - India 51
PL - Polonia 46
AR - Argentina 45
JP - Giappone 44
MX - Messico 44
NL - Olanda 37
AT - Austria 36
BD - Bangladesh 35
TR - Turchia 27
IQ - Iraq 24
ZA - Sudafrica 22
ID - Indonesia 21
EC - Ecuador 20
BE - Belgio 17
ES - Italia 16
UZ - Uzbekistan 16
PY - Paraguay 15
CL - Cile 12
CO - Colombia 12
RO - Romania 12
CZ - Repubblica Ceca 9
KE - Kenya 9
PK - Pakistan 9
VE - Venezuela 9
AE - Emirati Arabi Uniti 8
EG - Egitto 8
IR - Iran 8
PE - Perù 8
GR - Grecia 7
IL - Israele 7
JO - Giordania 7
LT - Lituania 7
AU - Australia 6
EU - Europa 6
MA - Marocco 6
KZ - Kazakistan 5
PH - Filippine 5
AZ - Azerbaigian 4
BO - Bolivia 4
DM - Dominica 4
NP - Nepal 4
PT - Portogallo 4
QA - Qatar 4
SA - Arabia Saudita 4
SN - Senegal 4
AL - Albania 3
CH - Svizzera 3
GY - Guiana 3
JM - Giamaica 3
KG - Kirghizistan 3
MY - Malesia 3
PA - Panama 3
SV - El Salvador 3
AM - Armenia 2
ET - Etiopia 2
HR - Croazia 2
HU - Ungheria 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AO - Angola 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
CV - Capo Verde 1
CY - Cipro 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GA - Gabon 1
GF - Guiana Francese 1
GM - Gambi 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
LV - Lettonia 1
MN - Mongolia 1
NI - Nicaragua 1
NO - Norvegia 1
Totale 42.312
Salva come PNG Salva come JPEG
Città #
Woodbridge 9.582
Wilmington 8.811
Houston 7.593
Fairfield 1.134
Singapore 1.050
Ann Arbor 873
Ashburn 730
Chandler 616
Hong Kong 578
Seattle 474
Cambridge 395
Jacksonville 377
Dublin 361
Beijing 331
Medford 269
Santa Clara 240
Dearborn 216
New York 211
Rome 170
Dallas 155
The Dalles 155
Los Angeles 146
Lawrence 128
Buffalo 98
Colorado Springs 89
Zhengzhou 79
Moscow 72
Mülheim 65
San Diego 65
Ho Chi Minh City 64
São Paulo 64
Hanoi 53
Milan 50
Menlo Park 46
Munich 45
Corona 34
London 33
Council Bluffs 31
Montreal 25
Norwalk 25
Nuremberg 25
Brooklyn 24
Redondo Beach 24
University Park 23
Boardman 21
Tokyo 21
Warsaw 21
Chicago 20
Denver 20
Phoenix 20
Falls Church 19
Belo Horizonte 18
Bologna 18
Johannesburg 18
Brussels 17
Mexico City 17
Nanjing 17
Hefei 16
Kraków 16
Mountain View 16
Naples 16
Shanghai 16
Toronto 16
Verona 16
Vienna 16
Rio de Janeiro 15
Atlanta 14
Poplar 14
Amsterdam 13
Orem 13
Redwood City 13
Washington 13
Brasília 12
Chennai 12
Da Nang 12
Kunming 12
Stockholm 12
San Francisco 11
Seoul 11
Dhaka 10
Frankfurt am Main 10
Haiphong 10
Helsinki 10
Jakarta 10
Palo Alto 10
Boston 9
Chiswick 9
Creede 9
Curitiba 9
Mumbai 9
Baghdad 8
Columbus 8
Del Norte 8
Engelhard 8
Guangzhou 8
Guayaquil 8
Nairobi 8
Nürnberg 8
Querétaro 8
Saint Petersburg 8
Totale 36.366
Salva come PNG Salva come JPEG
Nome #
Toward optimization of postremission therapy for residual disease-positive patients with acute myeloid leukemia 596
Acute foetal distress and umbilical cord blood banking 481
Possibility of long-term remission in patients with advanced hematologic malignancies after reduced intensity conditioning regimen (RIC) and allogeneic stem cell transplantation 479
Cistite emorragica da Adenovirus in un paziente sottoposto a trapianto di midollo osseo. vol. 39, p. 977-978 469
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA) 462
High expression levels of vla-4 (CD49d) on mobilised peripheral blood stem cells are associated with rapid engraftment in multiple myeloma patients receiving autologous transplant 461
Acute lymphoblastic leukemia subsequent to autoimmune hemolytic anemia: a case report 459
Consolidation and maintenance immunotherapy with rituximab improve clinical outcome in patients with B-cell chronic lymphocytic leukemia. 456
A simple prognostic scoring system for newly diagnosed cytogenetically normal acute myeloid leukemia: Retrospective analysis of 530 patients 455
High incidence of post-transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib-based regimens: a survey from the Rome transplant network. 452
Bortezomib-based therapy as induction regimen of an autograft program in front-line treatment of multiple myeloma with end-stage renal disease. 450
Bone marrow necrosis as a terminal complication of a very long-lasting polycythemia vera 449
IgG secreting lymphoplasmacytoid leukemia with massive skin involvement and very aggressive clinical course: an exceptionally rare observation. 444
Effects of single or split exposure of leukemic cells to temozolomide, combined with poly(ADP-ribose) polymerase inhibitors on cell growth, chromosomal aberrations and base excision repair components 443
Sequential combination of gemtuzumab ozogamicin and standard chemotherapy in older patients with newly diagnosed acute myeloid leukemia: Results of a randomized phase III trial of the EORTC and GIMEMA consortium (AML-17) 441
Obstacles to managing chemotherapy-induced nausea and vomiting in high-dose chemotherapy with stem cell transplant 435
Koebner's phenomenon as a rare mechanism of acute myeloid leukemia dissemination: report of two cases with a brief overview 434
The policy of the Rome Transplant Network (RTN), a metropolitan (2009). The Potential Application Of The Allogeneic Transplant By The Policy Of Widespread Donor Search: An Intention-To-Treat Analysis From The Rome Transplant Network. 433
Pure erythroid leukemia in advanced breast cancer. 431
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825 429
Hodgkin disease subsequent to follicular lymphoma on maintenance rituximab 429
Management of hematological malignancies in patients affected by renal failure 428
Cutaneous involvement in multiple myeloma and bortezomib 425
A Population-Based Study on Myelodysplastic Syndromes in the Lazio Region (Italy), Medical Miscoding and 11-Year Mortality Follow-Up: the Gruppo Romano-Laziale Mielodisplasie Experience of Retrospective Multicentric Registry 425
Unrelated Cord Blood transplantaion for children with high risk myelodysplastic syndrome 424
Characterization of Ph-negative abnormal clones emerging during imatinib therapy 424
Gelatinous degeneration of the bone marrow: two case reports showing different hematological features and clinical outcomes 423
Breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis [6] 416
Complex and multifaceted therapy-related myeloid neoplasm following laryngeal cancer treated with Cisplatin and radiotherapy 415
Cold autoimmune hemolytic anemia resolved by rituximab 414
Evaluation of biological features of cord blood units collected with different methods after cesarean section 414
Clinical significance of bax/bcl-2 ratio in chronic lymphocytic leukemia 414
Pancytopenia and severe sepsis in an adult case of congenital X-linked agammaglobulinemia (XLA). 413
Motor disability in malignant hematology: an epidemiological study on Italian hospitalized patients. 413
The prevention of oral mucositis in patients with blood cancers: current concepts and emerging landscapes 412
CD34+ cell mobilization for allogeneic progenitor cell transplantation: efficacy of a short course of G-CSF 412
Autologous bone marrow or peripheral blood stem cell transplantation for patients with chronic myelogenous leukaemia in chronic phase 412
Efficacy of caspofungin as secondary prophylaxis in patients undergoing allogeneic stem cell transplantation with prior pulmonary and/or systemic fungal infection 411
null 410
Dismal Outcome of Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia after Azacitidine Failure in a Daily-Life Setting. 410
Bortezomib-related colon mucositis in a multiple myeloma patient 408
Pretransplant minimal residual disease level predicts clinical outcome in patients with acute myeloid leukemia receiving high-dose chemotherapy and autologous stem cell transplantation 403
Unexplained severe Coombs-negative hemolytic anemia during treatment of refractory chronic lymphocytic leukemia with alemtuzumab. 403
breakthrough fusariosis in a patient with acute lymphoblastic leukemia receiving voriconazole prophylaxis 402
Home care management of patients affected by hematologic malignancies: A review 399
Bortezomib: Efficacy comparisons in solid tumors and hematologic malignancies 398
Nonmyeloablative allogeneic blood stem cell transplantation in patients with metastatic solid tumors 397
Immunophenotypic analysis in 119 patients with acute myeloid leukemia following a previous malignancy: a comparison with the immunophenotype of 231 de novo cases 394
A prospective study comparing quantitative Cytomegalovirus (CMV) polymerase chain reaction in plasma and pp65 392
Diagnosis of acute foetal distress does not preclude banking of umbilical cord blood units 391
Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. 391
Recombinant factor VIIa for the management of severe hemorrhages in patients with hematologic malignancies 390
Triple immunofluorescence evaluation of CD15, CD34 and Class-II expression by flow-cytometry in normal and leukemic bone marrows 387
null 385
Monitoring of minimal residual disease in adult acute myeloid leukemia using peripheral blood as an alternative source to bone marrow 384
Complete remission through blast cell differentiation in PLZF/RARα-positive acute promyelocytic leukemia: In vitro and in vivo studies 383
Case reports: zoster pain in haematological malignancies: effective pain relief with oxycodone in patients unresponsive to other analgesic measures 380
Molecular evidence of transient complete remission after autografting in Ph-/bcr rearranged chronic myelogenous leukaemia 380
Concomitant transformation of monoclonal gammopathy of undetermined significance to multiple myeloma and of essential thrombocythemia to acute biphenotypic leukemia 37 years after initial diagnosis 378
The genotype nucleophosmin mutated and FLT3-ITD negative is characterized by high bax/bcl-2 ratio and favourable outcome in acute myeloid leukaemia 377
Prolonged suppression of myeloid progenitor cell numbers after stopping interferon treatment for CML may necessitate delay in harvesting marrow cells for autografting 377
Therapy-induced Ph1 suppression in chronic myeloid leukemia: molecular and cytogenetic studies in patients treated with alpha-2b IFN, high-dose chemotherapy and autologous stem cell infusion 376
Venetoclax: Bcl-2 inhibition for the treatment of chronic lymphocytic leukemia 375
Opioids in pain management of blood-related malignancies 370
Up-regulation of activating and inhibitory NKG2 receptors in allogeneic and autologous hematopoietic stem cell grafts 369
Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial 367
Long-term hematological response in a patient with 5q- syndrome after suspension of lenalidomide therapy and further improvement with deferasirox therapy 365
Sleep complaints in hospitalized Italian patients with hematological malignancies 363
Homecare-based Motor Rehabilitation in Musculoskeletal Chronic Graft Versus Host Disease 363
DIAGNOSTIC PERFORMANCE AND SAFETY OF BRONCHOALVEOLAR LAVAGE IN THROMBOCYTOPENIC HAEMATOLOGICAL PATIENTS FOR ASPERGILLOSIS DIAGNOSIS: A MONOCENTRIC, RETROSPECTIVE EXPERIENCE 361
NOTCH1 mutations identify a chronic lymphocytic leukemia patient subset with worse prognosis in the setting of a rituximab-based induction and consolidation treatment. 358
Deregulation of the mitochondrial apoptotic machinery and development of molecular targeted drugs in acute myeloid leukemia 357
Extracorporeal photopheresis as first-line treatment in high-risk graft-versus-host disease 356
Primary pulmonary hodgkin lymphoma simulating a mediastinal tumour: an uncommon occurrence. 354
Stem cell mobilization after coronary artery bypass grafting. 353
Successful treatment of disseminated fusariosis with high dose liposomal amphotericin-B in a patient with acute lymphoblastic leukemia [4] 353
Patient-reported outcomes and quality of life assessment: New targets for new targeted therapy? 350
Fibrin glue therapy for severe hemorrhagic cystitis after allogeneic hematopoietic stem cell transplantation 342
Fibrin glue directly applied on damaged bladder mucosa during cystoscopy is highly effective to treat severe, refractory, haemorrhagic cystitis after allogeneic transplant 339
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemia. 334
CD69 is independently prognostic in chronic lymphocytic leukemia: acomprehensive clinical and biological profiling study 332
Pain management in multiple myeloma. 321
Hodgkin lymphoma in a mutated ZAP-70 negative B-cell Chronic Lymphocytic Leukemia patient 320
Complete regression of cutaneous lesions of refractory Ph+ ALL after 4 weeks of treatment with BMS-354825. 312
GIMEMA AML1310 trial of risk-adapted, MRD-directed therapy for young adults with newly diagnosed acute myeloid leukemia 291
The Potential Application of the Allogeneic Transplant by the Policy of Widespread Donor Search: an Intention- To-Treat Analysis from the Rome Transplant Network . 281
Gender, age and diagnosis effect on self-perceived pain in hematological patients: Retrospective analysis of two case series 279
The potential application of the allogeneic transplant according to a widespread donor search policy: an intention-to-treat analysis from the Rome Transplant Network 277
Pulmonary Infections in Patients with Myelodysplastic Syndromes Receiving Frontline Azacytidine Treatment 209
Prevention of chemotherapy-induced nausea and vomiting after high-dose melphalan and stem cell transplantation: review of the evidence and suggestions 193
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party 185
A sequential approach with imatinib, chemotherapy and transplant for adult Ph+ acute lymphoblastic leukemia: Final results of the GIMEMA LAL 0904 study 182
Double remission of simultaneously occurring secondary AML and CLL by venetoclax monotherapy 180
Long-term response in refractory AML following azacitidine-failed MDS by salvage decitabine-bridged allogenic transplantation 171
MATCHED-PAIR ANALYSIS OF TRANSPLANT FROM HAPLOIDENTICAL, UNMANIPULATED BONE MARROW DONOR VERSUS HLA IDENTICAL SIBLING FOR PATIENTS WITH HEMATOLOGICAL MALIGNANCIES 170
Bone marrow aspiration and biopsy-related pain management 168
Chemotherapy induced nausea and vomiting in bone marrow transplant: the unmet need 166
Adherence to recommendation for chemotherapy-induced nausea and vomiting prophylaxis: the proposal of a score 165
Management of pregnant chronic myeloid leukemia patients 157
Rehabilitation need and referrals in hematopoietic stem cell transplantation: the experience of Quality of Life Working Party of the Rome Transplant Network 157
Totale 37.023
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.752 0 0 0 0 0 706 742 660 144 197 232 71
2021/20221.280 61 170 54 52 45 113 76 76 70 103 80 380
2022/20231.956 184 144 60 184 124 370 153 91 142 344 118 42
2023/2024918 97 30 79 41 115 219 31 49 25 24 42 166
2024/20253.800 116 904 423 220 137 180 354 142 377 393 282 272
2025/20263.181 548 423 840 535 628 207 0 0 0 0 0 0
Totale 42.816